RADER-GeneticCounselingAlopeciaMastodyniaMultimodalityTherapyHER-2AyurvedaAdjuvantTherapyDoxorubicinGermlineMutationAntiemeticAdenocarcinomaBiopsyNeoplasmOvarianSuppressionMRICDK4/6InhibitorsHormoneReplacementTherapyEGFR(epidermalgrowth factorreceptor)LymphoscintigraphyCo-survivorProgestinHerceptinKappaEpsilonHormoneReceptorStatusDocetaxelMegestrolAcetateBreastCancerWomen ages40+ shouldhave a clinicalbreast examat least yearlyLCISAlcohol intakeof more thantwo drinks perday is a riskfactor for breastcancerPhyllodesTumorBOCALymphNodeStatusBRCAGeneGailModelNodePositiveSelf-examinationPalpationTumorGradeFibroadenoma1 in 8womenFor every 1,000screeningmammogramsperformed, aboutfive breast cancersare detected.ChemopreventionWomen ages20-39 yoshould have aclinical breastexam at leastevery 3 years.TamoxifenNodeNegativeCyclophosphamideTyrosine-KinaseInhibitorAnastrozoleMammography is alow-dose X-rayexamination thatcan detect breastcancer two yearsbefore it is largeenough to be feltACChemotherapyBreast cancer isthe leading causeof death in womenbetween the agesof 40 and 55AxillarySamplingPagetDiseaseLumpmTORInhibitorsCalcificationsDefinitiveSurgeryPhysicalactivity mayreduce therisk of breastcancersDown-StagingGuaranteedRenewableInsuranceECOGScoreEstimated 2,150 menwill be diagnosedwith breast cancerand approximately410 will die each yearLapatinibExcisionalBiopsyMetastasisImmunotherapyCystCheckpointInhibitorStagingAngiogenesisPaclitaxelDimplingRaloxifenePathologicResponseCachexiaCapecitabineMorpheaER+MultifocalTumorsMethotrexateFamilyHistoryAdvocacyKi-67RateCAMNeoadjuvantTherapyBrachytherapyOligometastasesRadiotherapyApoptosisEstrogenRelapseCytotoxicPalbociclib5-FluorouracilIn-situCarcinomaFlowCytometryGenomicTestingCMFChemotherapyGeneticPredispositionEstradiolChemotherapyInvasiveBreastCancerBevacizumabPI3KinaseInhibitorsTriplePositiveBreastCancerLumpectomyFISHBI-RADSAbsoluteRiskTripleNegativeBreastCancerBreastTomosynthesisDoseDenseTherapyAntibodyTherapyPrecisionMedicineAromataseInhibitorsIntraductalPapillomaCytostaticPARPInhibitorsAfrican-Americanwomen have a lowerchance of breastcancer overall, butthey are 40% morelikely to die frombreast cancer thanwhite womenMastectomyGeneMutationSERMBilateralProphylacticMastectomyRADER-GeneticCounselingAlopeciaMastodyniaMultimodalityTherapyHER-2AyurvedaAdjuvantTherapyDoxorubicinGermlineMutationAntiemeticAdenocarcinomaBiopsyNeoplasmOvarianSuppressionMRICDK4/6InhibitorsHormoneReplacementTherapyEGFR(epidermalgrowth factorreceptor)LymphoscintigraphyCo-survivorProgestinHerceptinKappaEpsilonHormoneReceptorStatusDocetaxelMegestrolAcetateBreastCancerWomen ages40+ shouldhave a clinicalbreast examat least yearlyLCISAlcohol intakeof more thantwo drinks perday is a riskfactor for breastcancerPhyllodesTumorBOCALymphNodeStatusBRCAGeneGailModelNodePositiveSelf-examinationPalpationTumorGradeFibroadenoma1 in 8womenFor every 1,000screeningmammogramsperformed, aboutfive breast cancersare detected.ChemopreventionWomen ages20-39 yoshould have aclinical breastexam at leastevery 3 years.TamoxifenNodeNegativeCyclophosphamideTyrosine-KinaseInhibitorAnastrozoleMammography is alow-dose X-rayexamination thatcan detect breastcancer two yearsbefore it is largeenough to be feltACChemotherapyBreast cancer isthe leading causeof death in womenbetween the agesof 40 and 55AxillarySamplingPagetDiseaseLumpmTORInhibitorsCalcificationsDefinitiveSurgeryPhysicalactivity mayreduce therisk of breastcancersDown-StagingGuaranteedRenewableInsuranceECOGScoreEstimated 2,150 menwill be diagnosedwith breast cancerand approximately410 will die each yearLapatinibExcisionalBiopsyMetastasisImmunotherapyCystCheckpointInhibitorStagingAngiogenesisPaclitaxelDimplingRaloxifenePathologicResponseCachexiaCapecitabineMorpheaER+MultifocalTumorsMethotrexateFamilyHistoryAdvocacyKi-67RateCAMNeoadjuvantTherapyBrachytherapyOligometastasesRadiotherapyApoptosisEstrogenRelapseCytotoxicPalbociclib5-FluorouracilIn-situCarcinomaFlowCytometryGenomicTestingCMFChemotherapyGeneticPredispositionEstradiolChemotherapyInvasiveBreastCancerBevacizumabPI3KinaseInhibitorsTriplePositiveBreastCancerLumpectomyFISHBI-RADSAbsoluteRiskTripleNegativeBreastCancerBreastTomosynthesisDoseDenseTherapyAntibodyTherapyPrecisionMedicineAromataseInhibitorsIntraductalPapillomaCytostaticPARPInhibitorsAfrican-Americanwomen have a lowerchance of breastcancer overall, butthey are 40% morelikely to die frombreast cancer thanwhite womenMastectomyGeneMutationSERMBilateralProphylacticMastectomy

BOCA Bingo - Call List

(Print) Use this randomly generated list as your call list when playing the game. There is no need to say the BINGO column name. Place some kind of mark (like an X, a checkmark, a dot, tally mark, etc) on each cell as you announce it, to keep track. You can also cut out each item, place them in a bag and pull words from the bag.


1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
61
62
63
64
65
66
67
68
69
70
71
72
73
74
75
76
77
78
79
80
81
82
83
84
85
86
87
88
89
90
91
92
93
94
95
96
97
98
99
100
101
102
103
104
105
106
107
108
109
110
111
112
113
114
115
116
117
118
119
120
121
122
123
124
125
126
  1. RAD
  2. ER-
  3. Genetic Counseling
  4. Alopecia
  5. Mastodynia
  6. Multimodality Therapy
  7. HER-2
  8. Ayurveda
  9. Adjuvant Therapy
  10. Doxorubicin
  11. Germline Mutation
  12. Antiemetic
  13. Adenocarcinoma
  14. Biopsy
  15. Neoplasm
  16. Ovarian Suppression
  17. MRI
  18. CDK4/6 Inhibitors
  19. Hormone Replacement Therapy
  20. EGFR (epidermal growth factor receptor)
  21. Lymphoscintigraphy
  22. Co-survivor
  23. Progestin
  24. Herceptin
  25. Kappa Epsilon
  26. Hormone Receptor Status
  27. Docetaxel
  28. Megestrol Acetate
  29. Breast Cancer
  30. Women ages 40+ should have a clinical breast exam at least yearly
  31. LCIS
  32. Alcohol intake of more than two drinks per day is a risk factor for breast cancer
  33. Phyllodes Tumor
  34. BOCA
  35. Lymph Node Status
  36. BRCA Gene
  37. Gail Model
  38. Node Positive
  39. Self-examination
  40. Palpation
  41. Tumor Grade
  42. Fibroadenoma
  43. 1 in 8 women
  44. For every 1,000 screening mammograms performed, about five breast cancers are detected.
  45. Chemoprevention
  46. Women ages 20-39 yo should have a clinical breast exam at least every 3 years.
  47. Tamoxifen
  48. Node Negative
  49. Cyclophosphamide
  50. Tyrosine-Kinase Inhibitor
  51. Anastrozole
  52. Mammography is a low-dose X-ray examination that can detect breast cancer two years before it is large enough to be felt
  53. AC Chemotherapy
  54. Breast cancer is the leading cause of death in women between the ages of 40 and 55
  55. Axillary Sampling
  56. Paget Disease
  57. Lump
  58. mTOR Inhibitors
  59. Calcifications
  60. Definitive Surgery
  61. Physical activity may reduce the risk of breast cancers
  62. Down-Staging
  63. Guaranteed Renewable Insurance
  64. ECOG Score
  65. Estimated 2,150 men will be diagnosed with breast cancer and approximately 410 will die each year
  66. Lapatinib
  67. Excisional Biopsy
  68. Metastasis
  69. Immunotherapy
  70. Cyst
  71. Checkpoint Inhibitor
  72. Staging
  73. Angiogenesis
  74. Paclitaxel
  75. Dimpling
  76. Raloxifene
  77. Pathologic Response
  78. Cachexia
  79. Capecitabine
  80. Morphea
  81. ER+
  82. Multifocal Tumors
  83. Methotrexate
  84. Family History
  85. Advocacy
  86. Ki-67 Rate
  87. CAM
  88. Neoadjuvant Therapy
  89. Brachytherapy
  90. Oligometastases
  91. Radiotherapy
  92. Apoptosis
  93. Estrogen
  94. Relapse
  95. Cytotoxic
  96. Palbociclib
  97. 5-Fluorouracil
  98. In-situ Carcinoma
  99. Flow Cytometry
  100. Genomic Testing
  101. CMF Chemotherapy
  102. Genetic Predisposition
  103. Estradiol
  104. Chemotherapy
  105. Invasive Breast Cancer
  106. Bevacizumab
  107. PI3 Kinase Inhibitors
  108. Triple Positive Breast Cancer
  109. Lumpectomy
  110. FISH
  111. BI-RADS
  112. Absolute Risk
  113. Triple Negative Breast Cancer
  114. Breast Tomosynthesis
  115. Dose Dense Therapy
  116. Antibody Therapy
  117. Precision Medicine
  118. Aromatase Inhibitors
  119. Intraductal Papilloma
  120. Cytostatic
  121. PARP Inhibitors
  122. African-American women have a lower chance of breast cancer overall, but they are 40% more likely to die from breast cancer than white women
  123. Mastectomy
  124. Gene Mutation
  125. SERM
  126. Bilateral Prophylactic Mastectomy